AKT1 and hepatocellular carcinoma: The somatic mutation S1113R of the phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 (PREX2) gene has been shown to promote migration and proliferation and activate the AKT pathway in hepatocellular carcinoma (HCC) [5].